MEDIA

This year’s BIO Asia-Taiwan 2025 was held at the Taipei Nangang Exhibition Center, Hall 1, attracting biotechnology professionals, industry leaders, researchers, and investors from around the world. Together, they are exploring collaborative opportunities and gaining deeper insights into Taiwan’s innovation and progress in the biotech sector.

 

 

GBC is showcasing its the CellBio™ circulating tumor cell detection product, a2000 CTC system, highlighting cutting-edge technologies in early cancer detection and monitoring. Visitors can also learn more about GBC’s high-sensitivity and high-precision diagnostic technology, including CLIA (chemiluminescent immunoassay) instruments and reagents, which are applicable to a wide range of clinical testing needs. The fully automated genetic nucleic acid detection and analysis system AIO M160 integrates DNA/RNA extraction, amplification, and data analysis, offering clinical laboratories enhanced efficiency and consistent diagnostic performance. 

 

Please stay tuned for GBC’s future developments and upcoming exhibitions worldwide. We warmly welcome all guests and partners to visit us and explore more cutting-edge technologies, products, and integrated solutions.